Do Intravaginal Devices Reduce Urinary Incontinence in Female Runners?

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Ottawa

About this trial

More than one in five females experience the embarrassment and shame of urine leakage while exercising and this urinary incontinence (UI) is a substantial barrier to exercise. As many as one in three females with UI report that they limit their physical activity due to incontinence: 11.6% by not exercising at all, 11.3% by exercising less and 12.4% by changing the type of exercise they perform. It is imperative to look for alternatives to manage this condition, as it is a key reason why females abandon the very physical exercise that is necessary to maintain or improve their physical and mental health and their quality of life.

While there is Grade A evidence for pelvic floor muscle training and some evidence for intravaginal pessaries to reduce symptoms of UI in general female populations, no study has evaluated the impact of conservative interventions specifically on UI experienced predominantly during running.

Eligibility criteria

Qualifiers

Females aged 18 years and over who run at least twice a week for a minimum of 10K/week (minimum speed of 6 km/h to ensure high impact), who have done so for at least 6 months (to ensure adequate duration of exposure), and who commit to continue the same amount during the study period

Who regularly (≥ 1 per week) experience urine leakage while running.

Disqualifiers

Any risk factors related to exercise;

Pain or musculoskeletal injury at the time of the screening;

History of urogenital surgery;

Symptoms of the female athlete triad;

Trial design

Treatments tested in this trial

  • Pessary Intervention
  • Tampon Intervention

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators